Introduction
Asymmetric transition-metal catalysts and enzymes have emerged as the most effective synthetic tools for the stereoselective preparation of many chiral compounds. The possibility to exploit different catalytic approaches fore nantio-and diastereoselective catalysis is ac hallenging topic in chemicals ynthesis, especially if controlo fm ultiple stereogenic centers is involved.
[1] Furthermore, the developmento fi mproved procedures by means of using less expensive, easy-to-handle, and more sustainable catalyst systems still remains an elusive goal.
Herein, we report as imple, inexpensive, and efficient catalyst system for simultaneous 1,4-conjugate addition and reduction steps on a,b-unsaturated carbonyl compounds through base-controlled transition-metalc atalysis or/andb yu sing yeasts under mild conditions at room temperature. In our case, ac ascade reactiona llowed the asymmetric synthesis of differently substituted diols through the formation of the corresponding chiral keto-alcoholsa nd diols by bioreduction. The first step is based on enriched keto-alcohol formationt hrough Cu II -catalyzed asymmetric boron conjugate addition to a,b-unsaturated carbonyl compounds. [2] In contrast to popularp rotocols involving the use of chiral Cu I for the enantioselective bborylation of a,b-unsaturated acceptors, those involving the use of chiral Cu II catalysts have been investigated only recently. In particular, the complexation of Schiff base bidentate ligands with copper hasb een shown to result in compounds with interesting catalytic properties. On the other hand, organoboranes are known as extremely useful and versatile synthetic intermediates for organic synthesis [3] that can also display biological activities. Here, for 1,4-conjugate addition to carbon-carbon doubleb onds, we used bis(pinacolato)diboron [B 2 (pin) 2 ], which is one of the mostp ractical tools for the establishmento fn ew CÀBb onds through transition-metal catalysis. [4] To enhance the catalytic performance of asymmetric catalytic boron conjugate addition, tripodal ligands, [5] based on the tetrahydroquinoline or quinolone scaffold, were incorporated into the Cu II complexes. This successful combinationl ed to keto-alcohol derivatives in an enantiomerically enriched form. As ubsequent bioreductions tep involving the use of different whole cells allowed the reduction of the keto-alcohol substratest ot he corresponding enriched chiral diols, [1a, 6] leaving the other isomer unreacted (Scheme 1). The obtained substratesare importantbuilding blocks in the synthesis of diverse organic molecules that are versatile elements in the pharmaceuticalfield. [7] Ac hemo-andb iocatalytic cascade approachw as applied for the stereoselective synthesis of hydroxy ketonesa nd the corresponding 1,3-diols. An ew class of tridentate N,N,O ligands was used with copper(II) complexes for the asymmetric b-borylation of a,b-unsaturated compounds. The complex containing ligand L5 emerged as the best performer,and it gave the organoborane derivatives with good ee values. The corresponding keto-alcohol compounds were then bioreduced by yeasts. The biotransformation set up with Rhodotorula rubra allowed (R)-keto-alcohols and (S,S)-diols to be obtained with up to 99 % ee and up to 99 % de in favor of the anti enantiomers.
Results and Discussion
Considering the use of Schiff bases and their corresponding reduced amines as ligandsi nc opper complexes for the asymmetric b-borylation of a,b-unsaturated carbonyl compounds, the tridentate ligandsw eree asily synthesized startingf rom 8-aminoquinoline and its chiral derivatives by condensation with salicylaldehyde in EtOH at room temperature for 5h.T hen, the corresponding amines were obtained by reduction with NaBH 4 in am ixture of THF/MeOH at 0 8Cf or 1h (Scheme2). Chiral 8-aminotetrahydroquinolines were previously synthesized and studied in our research group as ligands in metal complexes and were used as catalysts in the asymmetric transfer hydrogenation (ATH) of different ketones with good results. [8] In the case of ligand L1,r eduction to the corresponding amine did not proceed in the presence of different amountso f NaBH 4 or by using Pd/C (1, 5, or 10 %m olar equivalents) under aH 2 atmospherep ressure, probablyb ecause of the extensive double-bond conjugation of the substrate.
The copper(II)/L complexes, obtainedb yt reating the ligand with Cu(OAc) 2 in EtOH for 3hat room temperature, were completely characterized. Crystals of the copperc omplex bearing ligand L1 suitable for X-ray structurea nalysisw ere obtained by slow evaporation of a3 3% water/acetone solutiona tr oom temperature. The complex crystallized in the centrosymmetric P1 space group, with five molecules of water and one molecule of acetone, depicted as an ORTEP [9] view in Figure 1 . The complexi sm onomeric, and the central Cu II atom is coordinated by two nitrogen donor atoms,o ne hydroxy oxygen atom, and one oxygen atom from acetonei nas quare-planar arrangement. The bond lengthsa nd angles are within the expected ranges. Ligand L1 is nearly planar with am aximum deviation of 0.026(3) for the O1 atom. The crystal structure is consolidated by an extensive network of water contacts, and this leads to the formationo fs upramolecular chains running along the a axis perpendicular to the ligands. In addition, weak CpÀH···O water intermoleculari nteractions contribute to stabilize the crystal packing.
Catalytica symmetric b-borylation was conducted starting from different a,b-unsaturated carbonyl compounds. Different reactions olvents (Et 2 O, MeOH, EtOH, toluene, water,d ichloromethane, acetonitrile, and THF) were evaluated in the presence of variable amountso fM eOH as ah ydrogen donor (20-150 equiv.) . With all catalysts, good yields were observed within 18 hb yu sing 1,3-diphenyl-2-propenone as as tandard substrate. Catalytic experiments showed that the best results were obtained by using Et 2 Ow ith 50 equivalents of MeOH at room temperature (Table1).
The enantiomeric excess was evaluated directly on the organoborane compounds by HPLC analysis. Assignment of the configuration was achieved by comparison with the corresponding b-hydroxy keto derivatives reported in the literature after deprotectingt he organoborane compounds with NaBO 3 ·H 2 Oi nT HF/water for 1h.C onsidering that the best results wereo btained upon using L5 as the ligand (Table 1 , entry 5), the b-borylation reaction wase xtendedu nder the same reactionc onditions to other a,b-unsaturated carbonyl compounds (Table 2) .
For all the chalcone derivatives( Ta ble 1, entries 5-12),t he bborylation reactionp roducts gave very appreciable outcomes ORTEP [9] view of the asymmetric unit with an arbitrary atom-numberings cheme (ellipsoids are drawna t4 0% probability). Ha toms are shown as spheres of arbitrary radii. in terms of enantioselectivity,w ith the exception of 4-(4-nitrophenyl)but-3-en-2-one, for which the reaction did not proceed. Full conversion was insteadg enerally observed upon using chalcone derivatives as startingm aterials;i tw as observedt hat if the substituent on the benzylic moiety was in the para position, the enantioselectivity decreased and was close to ar acemate, apart from the methyl group (51 % ee;T able 2, entry 13). Therefore, different substituents in the ortho and meta positions were evaluated, and the enantioselectivity increased for the ÀCl and ÀOCH 3 groups going from the para positiont o the ortho position (Table 2, entries 8-12) ;o nt he other hand, the enantiomeric excess decreased in the case of the ÀCH 3 substituent (Table 2, entries 13-15) . These data agree with the proposed reaction mechanism, in that the substituent on the benzylic moiety plays apivotal role in the nucleophilic addition step to form an O-enolate in terms of steric hindrance or electronic properties (Scheme 3). [4a, 10] With the aim to combine asymmetric chemocatalysis with biocatalytic reactions, the ability of yeasts to reduce the carbonyl group of the resulting b-hydroxyk eto derivatives selectively by biotransformation was then evaluated. Racemic 3-hydroxy-1,3-diphenylpropan-1-one was synthesized through bborylation and deprotection by using ac opper(II) complex containing L1 as the ligand,and it was used as as tandard substrate for the screening of differentb iocatalysts.
[11] All reactions were performed in the presence of glucose( 50 gL
À1
)a sac osubstrate with as ubstrate concentration of 2gL À1 in phosphate buffer,a nd the biotransformation resultsw ere evaluated after 48 h.
The data showt hat good resultsw ere obtained for the biocatalytic reduction upon using whole cells of Rhodotorula rubra, Pichi etchellsii, Torulopsis magnoliae,a nd Torulopsis molischiana (Table 3 , entries 1, 5, 11,a nd 12) as biocatalysts. As good outcomes ensued by employing Rhodotorular ubra either in the enantioselective reduction of the carbonylm oiety (97 % ee,9 1%de,2 3% yield;T able 3, entry 1) or in the bioreductiono ft he hydroxy ketone substrate (65 % ee), this yeast seemedt ob et he best candidate as ab iocatalyst in the reduction reactiono fd ifferentr acemic 3-hydroxy ketones, which were eventually obtained by b-borylationa nd deprotection of the substrates reported in Ta ble 2b yu sing ac opperc atalyst containing achiral ligand L1 (Table 4) .
Upon using methyl aryl hydroxy ketones, the results in terms of stereoselectivity were modestb oth in the formation of the diols and in the resolution of the hydroxy ketone compounds( Ta ble 4, entries 1-4). In the case of biaryl hydroxy ketones, the best resultsw ere obtained with para-substituted compounds in terms of molar conversion,w hereas if the substituent wasi nt he meta position, the yield decreased;t he product was undetectable for substrates with ortho substituents. This behavior could be correlated to ac hange in steric hindrance of the substrate, as access to the active catalytic site could become challenging if the substituents on the phenyl ring were in ac ertain unfavorable position. The stereoselective control observed with the yeast seemed to confirmt his hypothesis. In fact, the predominance of one configuration of the enantiomers changed between the para-a nd meta-substituted substrates:i nt he first case, the dominant (S,S)-diol underlined that the yeast followed the Prelog rule, whereas in the presence of meta-substituted substrates, (R,R)-diols were formed (ante-Prelog rule) ( Table 4 , entries 6-8, 10, and 13 vs. entries9, 11,a nd 14). Excellent results in terms of stereoselectivity were obtained with 4-H, 4-Cl, and4 -CH 3 substituents for biocatalytic ketone reduction (Table 4, entries 5, 8, and 13) .
Acascade reaction was then set up taking into consideration the good results obtainedw ith the biocatalysis approach as regards the molarc onversion.T hus, compounds with or without as ubstituent in the para positiono ft he phenyl ring were evaluated. The cascade reaction involved first b-borylation/deprotection and then bioreduction. Although the enantioselectivity of the first step (chemocatalysis) was modest,this was an indispensablec onditionf or bypassing the issue of negligible molar [a] All reactionsw ere performed for 18 hb yu sing the Cu complex (5 mol %) in diethyl ether; c(substrate) final = 28 mm, c(catalyst) final = 1.4 mm.
[b] Conversion was determined by 1 HNMR spectroscopy.
[b] Data were compared by taking the average of threeindependent experiments. Enantiomeric excess was determined by HPLC with ac hiralc olumn (see the Experimental Section).
Scheme3.Proposed reaction mechanism.
ChemistryOpen 2018, 7,393 -400 www.chemistryopen.org 2018 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim conversion into diols as ac onsequenceo faprobablesubstrate inhibition effect in the biotransformations. Different substrate concentrations were examined to avoid this inhibition effect. Furthermore, the biocatalytic reduction startingf rom the corresponding diketones did not proceed in terms of product conversion (5 %y ield) or stereoselectivity.T he organoborylation catalyzed by ac omplex bearing ligand L5 led to the organoborane compound with the R configuration and variable enantiomeric excess values (7-51 % ee). Subsequently,t he solvent was removed in vacuo and NaBO 3 ·H 2 O( 3equiv.) in THF/H 2 O (1:3, 50 mg substrate/1 mL) was added. After 1h,p hosphate buffer( 0.1 m,p H7,5 0mL), glucose (50 gL À1 ), and Rhodotorula rubra whole cells were added to the previousu ntreated solution to work with af inal substrate concentration of 1mgmL
À1
for 48 h(Ta ble 5).
From the data reported in Ta ble 5, it was observed that in the presence of electron-donating groups or hydrogen as a substituent, (S,S)-diols were providedw ith high enantiomeric excessv alues (Table 5 , entries 1, 2, and 6). Excellent ee values were also obtained for (R)-hydroxy ketones, although in the [a] The ee value was determinedb yH PLC with ac hiral column( see the Experimental Section).
[b] Molarc onversion and de were calculated by 1 HNMR spectroscopy. [ b] The ee value was determined by HPLC with ac hiral column (seet he Experimental Section).
[c] The de was calculated by 1 HNMR spectroscopy. case of the substrate with a para-OCH 3 substituent, we believe that the average ee value is due to steric hindrance generated by the lone pair of electrons of the methoxy substituent in the pocket of the yeast. Regarding the resultso btained with electron-withdrawing substituents, only low enantiomeric excess values were achieved in the reduction of (S,S)-diols and in the resolution of (R)-hydroxy ketones (Table 5, entries 3-5) . In this case, it is conceivable that erosiono ft he biocatalyst performance is aresult of the low enantioselectivity of the chemoreaction.
Conclusions
In conclusion, ac ascade reaction combiningt ransition-metal complexes with biocatalysts was set up for the enantioselective synthesis of keto-alcohols and the corresponding 1,3-diols. An ew class of tridentate N,N,O pyridine-basedl igands was used for the first time in the b-borylation reactionw ith copper(II) complexes to afford, in the case of ligand L5,k etoalcohols in enriched formw ith up to 51 % ee,w hich was crucial for setting up the subsequent biotransformation. Rhodotorula rubra,u nder optimized condition reactions, gave (S,S)-diols (up to 99 % ee), and the S enantiomer of the keto-alcoholw as consumedc ompletely (up to 99 % ee for the unreacted R enantiomer) with both excellent enantio-and diastereoselectivities.
Experimental Section Synthetic Procedures
General 1 HNMR and 13 CNMR spectra were recorded in CDCl 3 by using a Bruker DRX Avance( 300 and 75 MHz) spectrometer equipped with anonreverse probe. Chemical shifts [ppm] are referenced to the residual solvent proton/carbon signal. Polarimetry analyses were performed with aP erkinElmer 343 Plus equipped with Na/Hal lamp. MS analyses were performed by using aT hermo Finnigan (MA, USA) LCQ Advantage system MS spectrometer with an electrospray ionization source and an ion-trap mass analyzer.M ass spectra were obtained by direct infusion of as ample solution in MeOH under ionization (ESI +). Catalytic reactions were monitored by HPLC analysis with aM erck-Hitachi L-7100 equipped with Detector UV6000LP and ac hiral column (AD, OJ-H Chiralcel, Lux Cellulose-4, Lux Cellulose-2 or Lux Amylose-2).
General Procedure for the Synthesis of Ligands L1-L3
8-Aminoquinoline (1.2 equiv.) was dissolved in EtOH (10 mL), and salicylaldehyde (1 equiv.) was added at room temperature. The mixture was stirred for 5h and then water (5 mL) was added. The organic layer was extracted with CH 2 Cl 2 (3 10 mL). Anhydrous Na 2 SO 4 was added, the mixture was filtered, and the solvent was removed in vacuo. The obtained product did not need further purification. 5, 145.5, 142.3, 135.9, 133.3, 132.4, 129.1, 126.5, 126.2, 121.3, 119.6, 118.7 118 .1, 117.6 ppm;F TIR (NaCl): ñ = 3468, 3368, 3050, 2917, 2894, 1661, 1617, 1372, 1150, 1114 
GeneralP rocedure for the Synthesis of Ligands L4 and L5
The ligand (1 equiv.) was dissolved in MeOH/THF (1:1, 5mL), and the mixture was cooled to 0 8C. NaBH 4 (0.5 equiv.) was added, and the mixture was stirred at room temperature for 1h.T he solution was quenched with saturated NH 4 Cl solution (4 mL) and was extracted with CH 2 Cl 2 (3 8mL). The combined organic layer was dried (Na 2 SO 4 ), and the solvent was evaporated. The obtained product did not need further purification. 01, 155.95, 146.87, 137.24, 132.63, 128.68, 128.33, 123.61, 122.38, 119.05, 116,49, 57.99, 50.79, 28.55, 28.44, 19 .74 ppm;F TIR (NaCl): ñ = 3282, 2924, 1924, 1690, 1589, 1456, 1259, 1037, 754 7, 155.1, 137.5, 129.1, 128.9, 128.8, 128.0, 123.7, 121.9, 116.2, 57.9, 50.7, 28.7, 28.2, 20.4, 19 .8 ppm;F TIR (NaCl) n = 3281, 2925, 2858, 1597, 1499, 1471, 1258, 1091, 1035, 816 
Synthesis of a,b-UnsaturatedKetones
An aqueous solution of sodium hydroxide (30 %, 25 mL) was slowly added to am ethanol solution (30 mL) of the appropriate acetophenone (1 equiv.). The solution was cooled to room temperature, and the appropriate benzaldehyde (1.2 equiv.) was added. The mixture was stirred at room temperature overnight and was then ChemistryOpen 2018, 7,393 -400 www.chemistryopen.org 2018 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim poured into water (100 mL). The obtained solid was filtered, washed with water until neutral pH, and recrystallized (ethanol). The chemical structure was confirmed on the basis of previously reported data. [12] General Procedure for AsymmetricB oron Conjugate Addition
Am ixture of Cu(OAc) 2 (5 %m ol), chiral ligand L1-L5 (6 %m ol), and B 2 (pin) 2 (1.2 equiv.) in Et 2 O( 7.5 mL) was stirred at room temperature for 1hunder an itrogen atmosphere. Am ixture of the a,b-unsaturated carbonyl compound (1 equiv.) and MeOH (50 equiv.) in Et 2 O( 2.5 mL) was added, and the mixture was stirred at room temperature for 15 h. The mixture was concentered in vacuo, the residue was dissolved in THF/H 2 O( 1.5:1, 4mL), and NaBO 3 ·H 2 Ow as added. The mixture was stirred for 2hand then filtered. The aqueous layer was extracted with EtOAc (2 5mL), and the combined organic layer was dried (Na 2 SO 4 ). The solvent was evaporated, and the enantiomeric excess of the product was checked by HPLC analysis. 8, 144.8, 143.0, 137.9, 129.7, 128.5, 127.6, 125.7, 120.8, 120.1, 112.3, 55.4, 47.5, 24.5 
General Procedure for the Biotransformation
The biotransformation screening was performed in 10 mL screwcapped test tubes by resuspending the yeast cells in 0.1 m phosphate buffer (pH 7, 5mL) containing glucose (50 gL À1 )a nd adding substrate (2 gL À1 )d issolved in DMSO (1 %). The mixtures were magnetically stirred at 28 8Cf or 48 h. The mixtures were extracted with diethyl ether (2 5mL), dried (Na 2 SO 4 ), and concentrated in vacuo.
The 1 HNMR and 13 CNMR spectra of 1-phenylbutane-1,3-diol, 1-(3-chlorophenyl)butane-1,3-diol, 1-(4-chlorophenyl)butane-1,3-diol, 1-(4-nitrophenyl)butane-1,3-diol, 1,3-diphenyl-1,3-propanediol, benzoyl(4'-methylbenzoyl)methane, and benzoyl(4'-chlorobenzoyl)methane correspond to those reported in the literature. [1a, b, 14] 4-(1,3-Dihydroxy-3-phenylpropyl)benzonitrile: 5, 143.6, 132.3, 128.7, 128.6, 128.1, 127.8, 126.3, 126.3, 126.0, 125.6, 125.4, 118.8, 111.2, 75.4 (anti) 4, 143.8, 128.9, 128.6, 128.5, 127.9, 127.7, 125.9, 125.8, 125.6, 125.5, 125.3, 75.2 (anti) 3, 143.8, 134.4, 129.7, 128.6, 128.5, 127.9, 127.7, 127.5, 125.9, 125.8, 125.6, 125.5, 123.7, 123.7, 75.1 (anti) 2, 136.4, 136.3, 128.6, 128.5, 127.6, 127.4, 126.9, 126.8, 125.7, 125.6, 114.0, 113.9, 74.9 (anti) 8, 145.9, 144.1, 129.6, 128.3, 127.7, 127.4, 125.7, 125.6, 117.8, 113.2, 112.8, 111.1, 75.0 (syn) 144.2, 136.4, 128.5, 128.4, 127.7, 127.6, 126.6, 126.5, 125.2, 125.1, 113.8, 74.9 (syn), 74.6 (syn), 71.7 (anti), 71.3 (anti), 55.3, 47.7 (syn) 5, 144.3, 138.0, 128.4, 128.3, 127.5, 127.2, 126.2, 126.3, 125.6, 122.6, 74.8, 71.4, 46.6, 24.8 7.56 (d, J = 7.2 Hz, 2H), 5H), 2H, syn), 2H, anti) 133.9, 130.4, 128.4, 127.7, 127.4, 127.3, 126.4, 125.3, 125.5, 125.1, 75.2 (anti) 
Analytical Conditions
The products were analyzed by 1 HNMR spectroscopy to determinate the molar conversion, whereas the diastereomeric and enantiomeric excess values were evaluated by HPLC analysis.
4-Hydroxy-4-phenylbutan-2-one: S isomer: t R = 21 min, R isomer: t R = 18.7 min;1 -phenylbutane-1,3-diol:( anti form) S,R isomer: t R = 16 min, R,S isomer: t R = 17 min, (syn form) R,R isomer: t R = 19.7 min, S,S isomer: t R = 21 min;c olumn:L ux cellulose-4, eluent:2 -propa- ChemistryOpen 2018, 7,393 -400 www.chemistryopen.org 4-(3-Chlorophenyl)-4-hydroxybutan-2-one: S isomer: t R = 15 min, R isomer: t R = 19 min;1 -(3-chlorophenyl)butane-1,3-diol:( anti form) S,R isomer: t R = 11 min, R,S isomer: t R = 15 min, (syn form) R,R isomer: t R = 11.5 min, S,S isomer: t R = 13 min;c olumn:L ux amylose-2, eluent:2 -propanol/hexane = 15:85, flow = 0.5 mL min
À1
, l = 216 nm.
4-(4-Chlorophenyl)-4-hydroxybutan-2-one: S isomer: t R = 18 min, R isomer: t R = 20 min;1 -(4-chlorophenyl)butane-1,3-diol:( anti form) S,R isomer: t R = 14 min, R,S isomer: t R = 24 min, (syn form) R,R isomer: t R = 13.5 min, S,S isomer: t R = 26 min;c olumn:L ux amylose-2, eluent:2 -propanol/hexane = 5:95, flow = 1.0 mL min À1 , l = 216 nm.
4-(4-Nitrophenyl)-4-hydroxybutan-2-one: S isomer: t R = 72 min, R isomer: t R = 65 min;4 -(4-nitrophenyl)butane-1,3-diol:(anti form) S,R isomer: t R = 33 min, R,S isomer: t R = 35 min, (syn form) R,R isomer: t R = 37 min, S,S isomer: t R = 40 min;c olumn:O J-H Chiralcel, eluent: ethanol/hexane = 5:95, flow = 1.0 mL min À1 , l = 254 nm.
3-Hydroxy-1,3-diphenylpropan-1-one: S isomer: t R = 24 min, R isomer: t R = 41 min;1 ,3-diphenyl-1,3-propanediol: meso form: t R = 13 min, R,R isomer: t R = 15.5 min, S,S isomer: t R = 18 min;c olumn: Lux amylose-2, eluent:e thanol/hexane = 10:90, flow = 1.0 mL min À1 , l = 216 nm.
4-(3-Hydroxy-3-phenylpropanoyl)benzonitrile: R isomer: t R = 36 min, S isomer: t R = 46 min;4 -(1,3-dihydroxy-3-phenylpropyl)benzonitrile: (anti form) S,S isomer: t R = 17 min, R,R isomer: t R = 19 min, (syn form) S,R isomer: t R = 8.8 min, R,S isomer: t R = 9.6 min;c olumn:L ux cellulose-4, eluent:2 -propanol/hexane = 3:97, flow = 1.0 mL min À1 , l = 216 nm.
3-Hydroxy-1-(4-trifluoromethylphenyl)-3-phenylpropan-1-one: R isomer: t R = 25.4 min, S isomer: t R = 37.5 min;1 -phenyl-3-[4-(trifluoromethyl)phenyl]propane-1,3-diol:( anti form) S,S isomer: t R = 30 min, R,R isomer: t R = 34.5 min;( syn form) S,R isomer: t R = 49 min, R,S isomer: t R = 51 min;c olumn:L ux cellulose-4, eluent:2 -propanol/hexane = 3:97, flow = 1.0 mL min À1 , l = 216 nm.
3-(4-Chlorophenyl)-3-hydroxy-1-phenylpropan-1-one: S isomer: t R = 37 min, R isomer: t R = 42 min;b enzoyl-(4'-chlorobenzoyl)methane: (anti form) S,S isomer: t R = 34 min, R,R isomer: t R = 21 min, (syn form) R,S isomer: t R = 18 min, S,R isomer: t R = 23.5 min;column:Lux amylose-2, eluent:e thanol/hexane = 5:95, flow = 1.0 mL min À1 , l = 220 nm.
3-(3-Chlorophenyl)-3-hydroxy-1-phenylpropan-1-one: R isomer: t R = 22 min, S isomer: t R = 29 min;1 -(3-chlorophenyl)-3-phenylpropane-1,3-diol:( anti form) S,S isomer: t R = 36 min, R,R isomer: t R = 41 min, (syn form) R,S isomer: t R = 62 min, S,R isomer: t R = 54 min;c olumn: Lux cellulose-4, eluent:2 -propanol/hexane = 3:97, flow = 1.0 mL min À1 , l = 216 nm.
3-Hydroxy-1-(4-methoxyphenyl)-3-phenylpropan-1-one: R isomer: t R = 76 min, S isomer: t R = 88 min;1 -(4-methoxyphenyl)-3-phenylpropane-1,3-diol:( anti form) S,S isomer: t R = 46 min, R,R isomer: t R = 50 min, (syn-form) S,R isomer: t R = 58 min, R,S isomer: t R = 69 min;c olumn:L ux amylose-2, eluent:2 -propanol/hexane = 10:90, flow = 0.8 mL min
, l = 220 nm.
3-Hydroxy-1-(3-methoxyphenyl)-3-phenylpropan-1-one: S isomer: t R = 57 min, R isomer: t R = 102 min;1 -(3-methoxyphenyl)-3-phenylpropane-1,3-diol:( anti form) S,S isomer: t R = 43 min, R,R isomer: t R = 48 min, (syn-form) S,R isomer: t R = 64 min, R,S isomer: t R = 68 min;c olumn:L ux amylose-2, eluent:e thanol/hexane = 5:95, flow = 1.0 mL min À1 , l = 220 nm.
3-Hydroxy-1-(2-methoxyphenyl)-3-phenylpropan-1-one: S isomer: t R = 12 min, R isomer: t R = 19 min;c olumn:A DC HIRALCEL, eluent: 2-propanol/hexane = 10:90, flow = 1.0 mL min
3-Hydroxy-3-phenyl-1-(p-tolyl)propan-1-one: R isomer: t R = 13.5 min, S isomer: t R = 20.5 min;b enzoyl-(4'-methylbenzoyl)methane:( anti form) S,S isomer: t R = 11 min, R,R isomer: t R = 17 min, (syn form) S,R isomer: t R = 16 min, R,S isomer: t R = 10 min;c olumn: Lux cellulose-4, eluent:e thanol/hexane = 10:90, flow = 1.0 mL min À1 , l = 216 nm.
3-Hydroxy-1-(3-methylphenyl)-3-phenylpropan-1-one: S isomer: t R = 14 min, R isomer: t R = 11 min;1 -phenyl-3-(m-tolyl)propane-1,3-diol:( anti form) S,S isomer: t R = 6min, R,R isomer: t R = 10 min, (syn form) S,R isomer: t R = 21 min, R,S isomer: t R = 24 min;c olumn:L ux cellulose-2, eluent:2 -propanol/hexane = 10:90, flow = 0.8 mL min À1 , l = 220 nm.
3-Hydroxy-1-(2-methylphenyl)-3-phenylpropan-1-one: S isomer: t R = 12 min, R isomer: t R = 13.5 min;c olumn:A DC HIRALCEL, eluent:2-propanol/hexane = 8:92, flow = 1.0 mL min
Cascade Reaction Procedure
Am ixture of Cu(OAc) 2 (5 %m ol), chiral ligand L5 (6 %m ol), and B 2 (pin) 2 (1.2 equiv.) in Et 2 O( 7.5 mL) was stirred at room temperature for 1hunder an itrogen atmosphere. Am ixture of the a,b-unsaturated ketone (1 equiv.) and MeOH (50 equiv.) in Et 2 O( 2.5 mL) was added, and the mixtures was stirred at room temperature for 15 h. The mixture was concentrated in vacuo, the residue was dissolved in THF/H 2 O( 1:3, 50 mg substrate/1 mL), and NaBO 3 ·H 2 O (5 equiv.) was added. The mixture was stirred for 1h. Rhodotorula rubra was then added to 0.1 m phosphate buffer (pH 7, 50 mL) containing glucose (50 gL À1 )t ow ork at af inal substrate concentration of 1mgmL
À1
.T he mixture was magnetically stirred at 28 8Cf or 48 h. The mixture was extracted with diethyl ether (2 5mL), dried (Na 2 SO 4 ), and concentrated in vacuo.
Material and Methods

Microorganisms: Culture Conditions
Strains from official collections or from our collection were routinely maintained on am alt extract (8 gL À1 agar 15 gL À1 ,p H5.5). To obtain cells for the biocatalytic activity tests, the microorganisms were grown on solid medium at 28 8Cf or 72 h, and then, they were cultured in 1000 mL Erlenmeyer flasks containing the medium (100 mL, OD 530nm mL À1 = 0.1 at t 0 ). The microorganisms were incubated at 28 8Cf or 48 ho nareciprocal shaker (100 rpm). The yeasts were grown on malt extract with 5gL À1 Difco yeast extract, pH 5.6. Fresh cells from submerged cultures were centrifuged (4000 g for 15 min at 4 8C) and washed with tap water before using. The cells used in the screening biotransformations were concentrated in aratio of 1:2.
Crystallography
Diffraction data for the crystal of complex/L1 [19] were collected by means of aE nraf-Nonius CAD4 four circle diffractometerw orking at ambient temperature with graphite-monochromated MoKa X-radiation (l = 0.7107 ). X-ray diffraction data in the 2 q range of 4t o 608 and in the (hkl)r ange AE h, AE k, + l were collected by using a ChemistryOpen 2018, 7,393 -400 www.chemistryopen.org 2018 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim profiled w-scan mode with scan angles of (1.2 + 0.35 tan q)8 and prescan speed of 4.128 min
À1
.A ccurate unit-cell parameters were obtained by aleast-squares fit of the 2 q values for 25 reflections in the 2 q range of 30 to 408.D ata reductions (including intensity integration, background, Lorentz, and polarization corrections) were performed with the WinGX package. [15] Absorption effects were evaluated with the psi-scan method, [16] and absorption correction was applied to the data (min/max transmission factors were 0.808/ 0.924). The structure was solved by direct methods (SIR-97) [17] and were completed by iterative cycles of full-matrix least-squares refinement on F o 2 and DF synthesis by using the SHELXL-97 [18] program (WinGX suite). All non-hydrogen atoms were refined anisotropically.T he positions of the Ha toms were detected in ad ifference Fourier and were refined with isotropic thermal factors or were introduced in calculated positions in their described geometries and allowed to ride on the attached carbon atom with fixed isotropic thermal parameters.
